Literature DB >> 7798996

The nature of apraxia in corticobasal degeneration.

B Okuda, H Tachibana.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7798996      PMCID： PMC1073248          DOI： 10.1136/jnnp.57.12.1548

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  6 in total

1.  Cortical-basal ganglionic degeneration.

Authors:  D E Riley; A E Lang; A Lewis; L Resch; P Ashby; O Hornykiewicz; S Black
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

2.  Corticobasal degeneration.

Authors:  W R Gibb; P J Luthert; C D Marsden
Journal:  Brain       Date:  1989-10       Impact factor: 13.501

3.  Both primary motor cortex and supplementary motor area play an important role in complex finger movement.

Authors:  H Shibasaki; N Sadato; H Lyshkow; Y Yonekura; M Honda; T Nagamine; S Suwazono; Y Magata; A Ikeda; M Miyazaki
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

4.  Palpatory apraxia.

Authors:  A Yamadori
Journal:  Eur Neurol       Date:  1982       Impact factor: 1.710

5.  The nature of apraxia in corticobasal degeneration.

Authors:  R Leiguarda; A J Lees; M Merello; S Starkstein; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

6.  Slowly progressive limb-kinetic apraxia with a decrease in unilateral cerebral blood flow.

Authors:  B Okuda; H Tachibana; K Kawabata; M Takeda; M Sugita
Journal:  Acta Neurol Scand       Date:  1992-07       Impact factor: 3.209
  6 in total
  2 in total

1.  Dyspraxia in a patient with corticobasal degeneration: the role of visual and tactile inputs to action.

Authors:  N L Graham; A Zeman; A W Young; K Patterson; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Apraxia and motor dysfunction in corticobasal syndrome.

Authors:  James R Burrell; Michael Hornberger; Steve Vucic; Matthew C Kiernan; John R Hodges
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.